Unmet Need
In the United States, colorectal cancer is the third most deadliest cancer with approximately 150,000 new cases projected for 2021 (see ACS). Efforts for early detection and diagnosis of colorectal cancer involve colonoscopies as well as fecal immunohistochemical tests that examine stool for the presence of hemoglobin. Despite these measures for early diagnosis, methods to improve patient access to care may increase the number of colorectal cancer cases detected each year leading to benefits in the survival of affected individuals. Therefore, there is a strong need for a colorectal cancer screen test that can improve on the status quo with ease of accessibility.
Technology Overview
Researchers at Johns Hopkins have developed a novel approach to detect the presence of hemoglobin in stool by use of a camera. This technology has the potential for mobile phone adoption and therefore wide-spread access for early screening of colorectal cancer. This invention has experimentally demonstrated the ability to detect hemoglobin at low levels that may be equivalent or lower than standard fecal immunochemical testing concentrations.
Stage of Development
Experimental data is available supporting proof of concept.
